InvestorsHub Logo
Followers 28
Posts 344
Boards Moderated 0
Alias Born 07/23/2013

Re: petemantx post# 5093

Monday, 02/03/2014 6:54:13 PM

Monday, February 03, 2014 6:54:13 PM

Post# of 55010
I don't read it exactly that way. I read that BAT will own the research and the right to commercialize it unless the research was done solely by xxii or for xxii. BAT will sell a non-exclusive, non-sublicensable right to all the research done by BAT to xxii at a reasonable price. As far as what was in place prior to the agreement, I read that xxii will provide all of that info to BAT.

The competitive issue is not very pressing as I see it. Remember BAT must pay 50% of the profit to xxii for the sublicensed activity. But xxii must pay 50% to BAT for anything xxii licenses or sublicenses too. If I were xxii, I would let BAT carry the ball. Different story in the U.S. though.

The licensing/sublicensing issue won't happen right away anyway as they have to get through the Research term of the agreement first.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent XXII News